日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Randomized Trial of Olaparib With or Without Cediranib for Metastatic Castration-Resistant Prostate Cancer: The Results From National Cancer Institute 9984

奥拉帕尼联合或不联合西地尼布治疗转移性去势抵抗性前列腺癌的随机试验:来自美国国家癌症研究所9984研究的结果

Kim, Joseph W; McKay, Rana R; Radke, Marc R; Zhao, Shilin; Taplin, Mary-Ellen; Davis, Nancy B; Monk, Paul; Appleman, Leonard J; Lara, Primo N Jr; Vaishampayan, Ulka N; Zhang, Jingsong; Paul, Asit K; Bubley, Glenn; Van Allen, Eliezer M; Unlu, Serhan; Huang, Ying; Loda, Massimo; Shapiro, Geoffrey I; Glazer, Peter M; LoRusso, Patricia M; Ivy, S Percy; Shyr, Yu; Swisher, Elizabeth M; Petrylak, Daniel P

[TSH-рroducing pituitary microadenoma: diagnostic problems in the debut of the disease]

[促甲状腺激素(TSH)分泌型垂体微腺瘤:疾病初期诊断难题]

Klimchuk, A V; Yatskov, I A; Bubley, K V; Enzel, D A; Sherbakov, A S

Prospective Evaluation of Clinical Outcomes Using a Multiplex Liquid Biopsy Targeting Diverse Resistance Mechanisms in Metastatic Prostate Cancer

利用多重液体活检靶向转移性前列腺癌的多种耐药机制,对临床结果进行前瞻性评估

Sperger, Jamie M; Emamekhoo, Hamid; McKay, Rana R; Stahlfeld, Charlotte N; Singh, Anupama; Chen, Xinyi E; Kwak, Lucia; Gilsdorf, Cole S; Wolfe, Serena K; Wei, Xiao X; Silver, Rebecca; Zhang, Zhenwei; Morris, Michael J; Bubley, Glenn; Feng, Felix Y; Scher, Howard I; Rathkopf, Dana; Dehm, Scott M; Choueiri, Toni K; Halabi, Susan; Armstrong, Andrew J; Wyatt, Alexander W; Taplin, Mary-Ellen; Zhao, Shuang G; Lang, Joshua M

Radiation and Androgen Deprivation Therapy With or Without Docetaxel in the Management of Nonmetastatic Unfavorable-Risk Prostate Cancer: A Prospective Randomized Trial

放射治疗联合或不联合多西他赛治疗非转移性高危前列腺癌:一项前瞻性随机试验

D'Amico, Anthony V; Xie, Wanling; McMahon, Elizabeth; Loffredo, Marian; Medeiros, Shana; Joseph, David; Denham, Jim; Kumar, Parvesh; Bubley, Glenn; Sullivan, Molly; Hellwig, Richard; Carlos Vera, Juan; Freter, Rolf; Jeffrey Baker, W; Wong, Jeffrey Y; Renshaw, Andrew A; Kantoff, Philip W

Phase II Multicenter Study of Enzalutamide in Metastatic Castration-Resistant Prostate Cancer to Identify Mechanisms Driving Resistance

恩杂鲁胺治疗转移性去势抵抗性前列腺癌的 II 期多中心研究旨在确定驱动耐药性的机制

Rana R McKay, Lucia Kwak, Jett P Crowdis, Jamie M Sperger, Shuang G Zhao, Wanling Xie, Lillian Werner, Rosina T Lis, Zhenwei Zhang, Xiao X Wei, Joshua M Lang, Eliezer M Van Allen, Rupal S Bhatt, Evan Y Yu, Peter S Nelson, Glenn J Bubley, R Bruce Montgomery, Mary-Ellen Taplin

Results of a Randomized Phase II Trial of Intense Androgen Deprivation Therapy prior to Radical Prostatectomy in Men with High-Risk Localized Prostate Cancer

一项随机II期临床试验的结果显示,在根治性前列腺切除术前对高危局限性前列腺癌患者进行强化雄激素剥夺疗法。

McKay, Rana R; Xie, Wanling; Ye, Huihui; Fennessy, Fiona M; Zhang, Zhenwei; Lis, Rosina; Calagua, Carla; Rathkopf, Dana; Laudone, Vincent P; Bubley, Glenn J; Einstein, David J; Chang, Peter K; Wagner, Andrew A; Parsons, J Kellogg; Preston, Mark A; Kilbridge, Kerry; Chang, Steven L; Choudhury, Atish D; Pomerantz, Mark M; Trinh, Quoc-Dien; Kibel, Adam S; Taplin, Mary-Ellen

Taxane resistance in prostate cancer is mediated by decreased drug-target engagement

前列腺癌中紫杉烷类药物的耐药性是由药物靶标结合度降低介导的

Ada Gjyrezi, Fang Xie, Olga Voznesensky, Prateek Khanna, Carla Calagua, Yang Bai, Justin Kung, Jim Wu, Eva Corey, Bruce Montgomery, Sandrine Mace, Diego A Gianolio, Glenn J Bubley, Steven P Balk, Paraskevi Giannakakou, Rupal S Bhatt

TRA-1-60-positive/CD45(low) cells found in the peripheral blood of prostate cancer patients with metastatic disease - A proof-of-concept study

在转移性前列腺癌患者外周血中发现TRA-1-60阳性/CD45低表达细胞——一项概念验证研究

Schäfer, Claudia; Ju, Yawen; Tak, Youngbin; Vazquez, Cesar; Han, Sangyoon J; Tan, Edwin; Shay, Jerry W; Holmqvist, Mats; Danuser, Gaudenz; Schopperle, William M; Bubley, Glenn

Evaluation of Intense Androgen Deprivation Before Prostatectomy: A Randomized Phase II Trial of Enzalutamide and Leuprolide With or Without Abiraterone

前列腺切除术前强化雄激素剥夺疗法的评估:恩扎卢胺和亮丙瑞林联合或不联合阿比特龙的随机II期试验

McKay, Rana R; Ye, Huihui; Xie, Wanling; Lis, Rosina; Calagua, Carla; Zhang, Zhenwei; Trinh, Quoc-Dien; Chang, Steven L; Harshman, Lauren C; Ross, Ashley E; Pienta, Kenneth J; Lin, Daniel W; Ellis, William J; Montgomery, Bruce; Chang, Peter; Wagner, Andrew A; Bubley, Glenn J; Kibel, Adam S; Taplin, Mary-Ellen

Propranolol exhibits activity against hemangiomas independent of beta blockade

普萘洛尔对血管瘤的活性与β受体阻滞剂无关。

Maiko Sasaki ,Paula E North ,Justin Elsey ,Jeffrey Bubley ,Shikha Rao ,Yoonhee Jung ,Shengnan Wu ,Ming-Hui Zou ,Brian P Pollack ,Jayanth Kumar ,Hartej Singh ,Jack L Arbiser